Ken Griffin Balchem Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$154.1 - $181.56 $1.9 Million - $2.23 Million	-12,300 Reduced 32.89%	25,100 $4.42 Million
Q2 2024 Aug 14, 2024	SELL	$138.5 - $156.63 $1.14 Million - $1.28 Million	-8,200 Reduced 17.98%	37,400 $5.76 Million
Q1 2024 May 15, 2024	BUY	$137.06 - $157.27 $5.14 Million - $5.9 Million	37,500 Added 462.96%	45,600 $7.07 Million
Q4 2023 Feb 14, 2024	BUY	$115.08 - $150.35 $287,700 - $375,875	2,500 Added 44.64%	8,100 $1.2 Million
Q3 2023 Nov 14, 2023	BUY	$123.38 - $142.72 $98,704 - $114,176	800 Added 16.67%	5,600 $694,000
Q2 2023 Aug 14, 2023	BUY	$122.28 - $136.64 $244,560 - $273,280	2,000 Added 71.43%	4,800 $647,000
Q1 2023 May 15, 2023	SELL	$117.39 - $142.06 $105,651 - $127,854	-900 Reduced 24.32%	2,800 $354,000
Q4 2022 Feb 14, 2023	BUY	$120.16 - $142.73 $444,592 - $528,101	3,700 New	3,700 $451,000

372

28.3M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.71B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.